MetaCap

Turn Therapeutics Statistics

NASDAQ: TTRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.10-0.545 (-6.31%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Turn Therapeutics by the numbers

Turn Therapeutics has a market capitalization of $247.5 million based on 30.57M shares outstanding. With trailing EPS of $-0.43, Turn Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.5% below its 50-day average and 9.9% above its 200-day average.

Average daily trading volume is 119.32K shares, or about $965,879 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TTRX valuation vs. peer median

TTRX compared with the median of 8 peer companies
MetricTTRXPeer medianDifference
Market cap$247.49M$258.72M-4%
Avg. volume119.32K423.72K-72%

Peer median across 8 companies: QTTB, LFCR, CAMP, PRLD, ALT, EBS, VCRE, GALT.

Valuation

Price and trading

Previous close
8.64
Open
8.85
Day range
7.93 – 9.20
52-week range
2.70 – 16.45
52-week change
+147.55%
Beta
—
Volume
82.67K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
247.49M
Forward Pe
-53.97
Eps
-0.43
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
16.45
Week52 Low
2.70
Avg Volume
119.32K
Shares Outstanding
30.57M
Ma50
11.32
Ma200
7.37
Earnings Date
Nov 9, 2026
Pct From52w High
-50.79%
Pct From52w Low
199.81%

Related